34
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Proteins and Carbohydrates from Red Seaweeds: Evidence for Beneficial Effects on Gut Function and Microbiota

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Based on their composition, marine algae, and namely red seaweeds, are good potential functional foods. Intestinal mucosal barrier function refers to the capacity of the intestine to provide adequate containment of luminal microorganisms and molecules. Here, we will first outline the component of seaweeds and will summarize the effects of these on the regulation of mucosal barrier function. Special attention will be paid to unique components of red seaweeds: proteins and derived peptides (e.g., phycobiliproteins, glycoproteins that contain “cellulose binding domains”, phycolectins and the related mycosporine-like amino acids) together with polysaccharides (e.g., floridean starch and sulfated galactans, such as carrageenans, agarans and “ dl-hybrid”) and minerals. These compounds have been shown to exert prebiotic effects, to regulate intestinal epithelial cell, macrophage and lymphocyte proliferation and differentiation and to modulate the immune response. Molecular mechanisms of action of peptides and polysaccharides are starting to be elucidated, and evidence indicating the involvement of epidermal growth factor receptor (EGFR), insulin-like growth factor receptor (IGFR), Toll-like receptors (TLR) and signal transduction pathways mediated by protein kinase B (PKB or AKT), nuclear factor-κB (NF-κB) and mitogen activated protein kinases (MAPK) will also be summarized. The need for further research is clear, but in vivo experiments point to an overall antiinflammatory effect of these algae, indicating that they can reinforce membrane barrier function.

          Related collections

          Most cited references114

          • Record: found
          • Abstract: not found
          • Article: not found

          Carrageenans: Biological properties, chemical modifications and structural analysis – A review

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Seaweed proteins

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.

              Liver fibrosis occurs as a wound-healing scar response following chronic liver inflammation including alcoholic liver disease, non-alcoholic steatohepatitis, viral hepatitis, cholestatic liver disease and autoimmune liver diseases. The liver has a unique vascular system within the gastrointestinal tract, as the majority of the liver's blood supply comes from the intestine through the portal vein. When the intestinal barrier function is disrupted, an increase in intestinal permeability leads to the translocation of intestine-derived bacterial products such as lipopolysaccharide (LPS) and unmethylated CpG containing DNA to the liver via the portal vein. These gut-derived bacterial products stimulate innate immune receptors, namely Toll-like receptors (TLRs), in the liver. TLRs are expressed on Kupffer cells, endothelial cells, dendritic cells, biliary epithelial cells, hepatic stellate cells, and hepatocytes. TLRs activate these cells to contribute to acute and chronic liver diseases. This review summarizes recent studies investigating the role of TLRs, intestinal microbiota and bacterial translocation in liver fibrosis, alcoholic liver disease and non-alcoholic steatohepatitis.
                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                Mar Drugs
                Mar Drugs
                marinedrugs
                Marine Drugs
                MDPI
                1660-3397
                20 August 2015
                August 2015
                : 13
                : 8
                : 5358-5383
                Affiliations
                [1 ]Instituto de Tecnología de Alimentos, Facultad de Ingeniería Química, Universidad Nacional del Litoral, 1° de Mayo 3250, (3000) Santa Fe, República Argentina; E-Mails: rec_704@ 123456yahoo.com.ar (R.E.C.); sdrago@ 123456fiq.unl.edu.ar (S.R.D.)
                [2 ]Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Av. Rivadavia 1917 (C1033AAJ), Ciudad Autónoma de Buenos Aires, República Argentina
                [3 ]Department of Pharmacology, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Universidad de Granada, Campus de Cartuja s/n, 18071 Granada, Spain; E-Mail: fsanchez@ 123456ugr.es
                [4 ]Instituto de Ciencia y Tecnología de los Alimentos José Mataix, Universidad de Granada, 18071 Granada, Spain
                [5 ]Department of Biochemistry and Molecular Biology II, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Universidad de Granada, Campus de Cartuja s/n, 18071 Granada, Spain
                [6 ]Instituto de Investigación Biosanitaria. ibs. GRANADA, University of Granada, 18071 Granada, Spain
                Author notes
                [* ]Author to whom correspondence should be addressed; E-Mail: omartine@ 123456ugr.es ; Tel.: +34-958-241-305; Fax: +34-958-248-960.
                Article
                marinedrugs-13-05358
                10.3390/md13085358
                4557026
                26308006
                dfbd2ad6-90df-49c3-884d-935881b4bb85
                © 2015 by the authors; licensee MDPI, Basel, Switzerland.

                This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 01 June 2015
                : 04 August 2015
                Categories
                Review

                Pharmacology & Pharmaceutical medicine
                red seaweeds,sulfated galactans,bioactive peptides,rhodophyta,mucosal barrier function,immunomodulation,cell differentiation,cell proliferation,nf-κb,mapk

                Comments

                Comment on this article